Cargando…
Seroprevalence of SARS-CoV-2 antibodies in social housing areas in Denmark
BACKGROUND: COVID-19 is thought to be more prevalent among ethnic minorities and individuals with low socioeconomic status. We aimed to investigate the prevalence of SARS-CoV-2 antibodies during the COVID-19 pandemic among citizens 15 years or older in Denmark living in social housing (SH) areas. ME...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830972/ https://www.ncbi.nlm.nih.gov/pubmed/35144550 http://dx.doi.org/10.1186/s12879-022-07102-1 |
_version_ | 1784648394636001280 |
---|---|
author | Fogh, Kamille Eriksen, Alexandra R. R. Hasselbalch, Rasmus B. Kristensen, Emilie Sofie Bundgaard, Henning Nielsen, Susanne D. Jørgensen, Charlotte S. Scharff, Bibi F. S. S. Erikstrup, Christian Sækmose, Susanne G. Holm, Dorte K. Aagaard, Bitten Norsk, Jakob Nielsen, Pernille Brok Kristensen, Jonas H. Østergaard, Lars Ellermann-Eriksen, Svend Andersen, Berit Nielsen, Henrik Johansen, Isik S. Wiese, Lothar Simonsen, Lone Fischer, Thea K. Folke, Fredrik Lippert, Freddy Ostrowski, Sisse R. Ethelberg, Steen Koch, Anders Vangsted, Anne-Marie Krause, Tyra Grove Fomsgaard, Anders Nielsen, Claus Ullum, Henrik Skov, Robert Iversen, Kasper |
author_facet | Fogh, Kamille Eriksen, Alexandra R. R. Hasselbalch, Rasmus B. Kristensen, Emilie Sofie Bundgaard, Henning Nielsen, Susanne D. Jørgensen, Charlotte S. Scharff, Bibi F. S. S. Erikstrup, Christian Sækmose, Susanne G. Holm, Dorte K. Aagaard, Bitten Norsk, Jakob Nielsen, Pernille Brok Kristensen, Jonas H. Østergaard, Lars Ellermann-Eriksen, Svend Andersen, Berit Nielsen, Henrik Johansen, Isik S. Wiese, Lothar Simonsen, Lone Fischer, Thea K. Folke, Fredrik Lippert, Freddy Ostrowski, Sisse R. Ethelberg, Steen Koch, Anders Vangsted, Anne-Marie Krause, Tyra Grove Fomsgaard, Anders Nielsen, Claus Ullum, Henrik Skov, Robert Iversen, Kasper |
author_sort | Fogh, Kamille |
collection | PubMed |
description | BACKGROUND: COVID-19 is thought to be more prevalent among ethnic minorities and individuals with low socioeconomic status. We aimed to investigate the prevalence of SARS-CoV-2 antibodies during the COVID-19 pandemic among citizens 15 years or older in Denmark living in social housing (SH) areas. METHODS: We conducted a study between January 8th and January 31st, 2021 with recruitment in 13 selected SH areas. Participants were offered a point-of-care rapid SARS-CoV-2 IgM and IgG antibody test and a questionnaire concerning risk factors associated with COVID-19. As a proxy for the general Danish population we accessed data on seroprevalence from Danish blood donors (total Ig ELISA assay) in same time period. RESULTS: Of the 13,279 included participants, 2296 (17.3%) were seropositive (mean age 46.6 (SD 16.4) years, 54.2% female), which was 3 times higher than in the general Danish population (mean age 41.7 (SD 14.1) years, 48.5% female) in the same period (5.8%, risk ratios (RR) 2.96, 95% CI 2.78–3.16, p > 0.001). Seropositivity was higher among males (RR 1.1, 95% CI 1.05–1.22%, p = 0.001) and increased with age, with an OR seropositivity of 1.03 for each 10-year increase in age (95% CI 1.00–1.06, p = 0.031). Close contact with COVID-19-infected individuals was associated with a higher risk of infection, especially among household members (OR 5.0, 95% CI 4.1–6.2 p < 0,001). Living at least four people in a household significantly increased the OR of seropositivity (OR 1.3, 95% CI 1.0–1.6, p = 0.02) as did living in a multi-generational household (OR 1.3 per generation, 95% CI 1.1–1.6, p = 0.003). Only 1.6% of participants reported not following any of the national COVID-19 recommendations. CONCLUSIONS: Danish citizens living in SH areas of low socioeconomic status had a three times higher SARS-CoV-2 seroprevalence compared to the general Danish population. The seroprevalence was significantly higher in males and increased slightly with age. Living in multiple generations households or in households of more than four persons was a strong risk factor for being seropositive. Results of this study can be used for future consideration of the need for preventive measures in the populations living in SH areas. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-022-07102-1. |
format | Online Article Text |
id | pubmed-8830972 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-88309722022-02-11 Seroprevalence of SARS-CoV-2 antibodies in social housing areas in Denmark Fogh, Kamille Eriksen, Alexandra R. R. Hasselbalch, Rasmus B. Kristensen, Emilie Sofie Bundgaard, Henning Nielsen, Susanne D. Jørgensen, Charlotte S. Scharff, Bibi F. S. S. Erikstrup, Christian Sækmose, Susanne G. Holm, Dorte K. Aagaard, Bitten Norsk, Jakob Nielsen, Pernille Brok Kristensen, Jonas H. Østergaard, Lars Ellermann-Eriksen, Svend Andersen, Berit Nielsen, Henrik Johansen, Isik S. Wiese, Lothar Simonsen, Lone Fischer, Thea K. Folke, Fredrik Lippert, Freddy Ostrowski, Sisse R. Ethelberg, Steen Koch, Anders Vangsted, Anne-Marie Krause, Tyra Grove Fomsgaard, Anders Nielsen, Claus Ullum, Henrik Skov, Robert Iversen, Kasper BMC Infect Dis Research Article BACKGROUND: COVID-19 is thought to be more prevalent among ethnic minorities and individuals with low socioeconomic status. We aimed to investigate the prevalence of SARS-CoV-2 antibodies during the COVID-19 pandemic among citizens 15 years or older in Denmark living in social housing (SH) areas. METHODS: We conducted a study between January 8th and January 31st, 2021 with recruitment in 13 selected SH areas. Participants were offered a point-of-care rapid SARS-CoV-2 IgM and IgG antibody test and a questionnaire concerning risk factors associated with COVID-19. As a proxy for the general Danish population we accessed data on seroprevalence from Danish blood donors (total Ig ELISA assay) in same time period. RESULTS: Of the 13,279 included participants, 2296 (17.3%) were seropositive (mean age 46.6 (SD 16.4) years, 54.2% female), which was 3 times higher than in the general Danish population (mean age 41.7 (SD 14.1) years, 48.5% female) in the same period (5.8%, risk ratios (RR) 2.96, 95% CI 2.78–3.16, p > 0.001). Seropositivity was higher among males (RR 1.1, 95% CI 1.05–1.22%, p = 0.001) and increased with age, with an OR seropositivity of 1.03 for each 10-year increase in age (95% CI 1.00–1.06, p = 0.031). Close contact with COVID-19-infected individuals was associated with a higher risk of infection, especially among household members (OR 5.0, 95% CI 4.1–6.2 p < 0,001). Living at least four people in a household significantly increased the OR of seropositivity (OR 1.3, 95% CI 1.0–1.6, p = 0.02) as did living in a multi-generational household (OR 1.3 per generation, 95% CI 1.1–1.6, p = 0.003). Only 1.6% of participants reported not following any of the national COVID-19 recommendations. CONCLUSIONS: Danish citizens living in SH areas of low socioeconomic status had a three times higher SARS-CoV-2 seroprevalence compared to the general Danish population. The seroprevalence was significantly higher in males and increased slightly with age. Living in multiple generations households or in households of more than four persons was a strong risk factor for being seropositive. Results of this study can be used for future consideration of the need for preventive measures in the populations living in SH areas. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-022-07102-1. BioMed Central 2022-02-10 /pmc/articles/PMC8830972/ /pubmed/35144550 http://dx.doi.org/10.1186/s12879-022-07102-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Fogh, Kamille Eriksen, Alexandra R. R. Hasselbalch, Rasmus B. Kristensen, Emilie Sofie Bundgaard, Henning Nielsen, Susanne D. Jørgensen, Charlotte S. Scharff, Bibi F. S. S. Erikstrup, Christian Sækmose, Susanne G. Holm, Dorte K. Aagaard, Bitten Norsk, Jakob Nielsen, Pernille Brok Kristensen, Jonas H. Østergaard, Lars Ellermann-Eriksen, Svend Andersen, Berit Nielsen, Henrik Johansen, Isik S. Wiese, Lothar Simonsen, Lone Fischer, Thea K. Folke, Fredrik Lippert, Freddy Ostrowski, Sisse R. Ethelberg, Steen Koch, Anders Vangsted, Anne-Marie Krause, Tyra Grove Fomsgaard, Anders Nielsen, Claus Ullum, Henrik Skov, Robert Iversen, Kasper Seroprevalence of SARS-CoV-2 antibodies in social housing areas in Denmark |
title | Seroprevalence of SARS-CoV-2 antibodies in social housing areas in Denmark |
title_full | Seroprevalence of SARS-CoV-2 antibodies in social housing areas in Denmark |
title_fullStr | Seroprevalence of SARS-CoV-2 antibodies in social housing areas in Denmark |
title_full_unstemmed | Seroprevalence of SARS-CoV-2 antibodies in social housing areas in Denmark |
title_short | Seroprevalence of SARS-CoV-2 antibodies in social housing areas in Denmark |
title_sort | seroprevalence of sars-cov-2 antibodies in social housing areas in denmark |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830972/ https://www.ncbi.nlm.nih.gov/pubmed/35144550 http://dx.doi.org/10.1186/s12879-022-07102-1 |
work_keys_str_mv | AT foghkamille seroprevalenceofsarscov2antibodiesinsocialhousingareasindenmark AT eriksenalexandrarr seroprevalenceofsarscov2antibodiesinsocialhousingareasindenmark AT hasselbalchrasmusb seroprevalenceofsarscov2antibodiesinsocialhousingareasindenmark AT kristensenemiliesofie seroprevalenceofsarscov2antibodiesinsocialhousingareasindenmark AT bundgaardhenning seroprevalenceofsarscov2antibodiesinsocialhousingareasindenmark AT nielsensusanned seroprevalenceofsarscov2antibodiesinsocialhousingareasindenmark AT jørgensencharlottes seroprevalenceofsarscov2antibodiesinsocialhousingareasindenmark AT scharffbibifss seroprevalenceofsarscov2antibodiesinsocialhousingareasindenmark AT erikstrupchristian seroprevalenceofsarscov2antibodiesinsocialhousingareasindenmark AT sækmosesusanneg seroprevalenceofsarscov2antibodiesinsocialhousingareasindenmark AT holmdortek seroprevalenceofsarscov2antibodiesinsocialhousingareasindenmark AT aagaardbitten seroprevalenceofsarscov2antibodiesinsocialhousingareasindenmark AT norskjakob seroprevalenceofsarscov2antibodiesinsocialhousingareasindenmark AT nielsenpernillebrok seroprevalenceofsarscov2antibodiesinsocialhousingareasindenmark AT kristensenjonash seroprevalenceofsarscov2antibodiesinsocialhousingareasindenmark AT østergaardlars seroprevalenceofsarscov2antibodiesinsocialhousingareasindenmark AT ellermanneriksensvend seroprevalenceofsarscov2antibodiesinsocialhousingareasindenmark AT andersenberit seroprevalenceofsarscov2antibodiesinsocialhousingareasindenmark AT nielsenhenrik seroprevalenceofsarscov2antibodiesinsocialhousingareasindenmark AT johansenisiks seroprevalenceofsarscov2antibodiesinsocialhousingareasindenmark AT wieselothar seroprevalenceofsarscov2antibodiesinsocialhousingareasindenmark AT simonsenlone seroprevalenceofsarscov2antibodiesinsocialhousingareasindenmark AT fischertheak seroprevalenceofsarscov2antibodiesinsocialhousingareasindenmark AT folkefredrik seroprevalenceofsarscov2antibodiesinsocialhousingareasindenmark AT lippertfreddy seroprevalenceofsarscov2antibodiesinsocialhousingareasindenmark AT ostrowskisisser seroprevalenceofsarscov2antibodiesinsocialhousingareasindenmark AT ethelbergsteen seroprevalenceofsarscov2antibodiesinsocialhousingareasindenmark AT kochanders seroprevalenceofsarscov2antibodiesinsocialhousingareasindenmark AT vangstedannemarie seroprevalenceofsarscov2antibodiesinsocialhousingareasindenmark AT krausetyragrove seroprevalenceofsarscov2antibodiesinsocialhousingareasindenmark AT fomsgaardanders seroprevalenceofsarscov2antibodiesinsocialhousingareasindenmark AT nielsenclaus seroprevalenceofsarscov2antibodiesinsocialhousingareasindenmark AT ullumhenrik seroprevalenceofsarscov2antibodiesinsocialhousingareasindenmark AT skovrobert seroprevalenceofsarscov2antibodiesinsocialhousingareasindenmark AT iversenkasper seroprevalenceofsarscov2antibodiesinsocialhousingareasindenmark |